Testosterone Therapy, HRT, and Sexual Health

Testosterone therapy, hormone replacement therapy, and sexual health are among the most rapidly evolving—and frequently misunderstood—areas of modern clinical practice. New research, updated guidelines, FDA labeling changes, and growing patient demand have transformed the landscape, creating both opportunities and challenges for healthcare providers. Yet despite their increasing importance, these topics remain underrepresented in traditional medical education, leaving many clinicians uncertain about how to apply the latest evidence in practice. Even experienced providers may struggle to keep pace with emerging concepts, evolving treatment strategies, and ongoing controversies in the field.
 
This innovative three-day program addresses those gaps head-on. Nearly 40% of men over the age of 45 have clinically low testosterone levels, while sexual dysfunction affects approximately 40% of both men and women. At the same time, advances in hormone replacement therapy for women—including emerging evidence on testosterone therapy and recent FDA labeling changes—have created an urgent need for updated clinical guidance.
 
Under the leadership of Abraham Morgentaler, MD, FACS, together with co-course directors Mohit Khera, MD, MPH, MBA, and Rachel S. Rubin, MD, this course brings together an outstanding multidisciplinary faculty to examine the most important issues in hormone therapy and sexual medicine. Through lectures, case discussions, debates, and interactive question-and-answer sessions, faculty will separate hype from science and provide practical approaches that can be immediately applied in clinical practice.
 
New for 2027, the expanded curriculum provides comprehensive coverage of women's hormones and sexual health alongside the course's longstanding focus on testosterone therapy and men's health. Dedicated sessions will address hormone replacement therapy, testosterone therapy in women, sexual dysfunction, breast cancer survivorship, and other complex clinical scenarios.
 
Additional sessions will explore fertility preservation, cardiovascular and prostate safety, post-finasteride syndrome, psychosexual health, emerging technologies, and the evolving role of AI and digital intimacy in sexual medicine—making this one of the most comprehensive educational offerings available in the field today.

Program Highlights

• The role of testosterone in men's health and healthy aging
• Hormone replacement therapy in women: rationale, guidelines, and clinical application
• Testosterone therapy in women: benefits, safety, and prescribing strategies
• Testosterone therapy in men with prostate cancer: what does the evidence show?
• Cardiovascular safety and risk management
• The who, when, and why of testosterone therapy
• The TRAVERSE Trial and its impact on clinical practice
• FDA labeling changes and what they mean for clinicians
• HRT in women with a history of breast cancer
• Female sexual dysfunction, including hypoactive sexual desire disorder
• Recognition and management of treatment-related adverse effects
• Practical approaches to couples with sexual health concerns
• Evaluation and treatment of erectile dysfunction and Peyronie's disease
• Post-finasteride syndrome: diagnosis and management
• Testosterone and mental health
• Tech Sex tech, chatbots, and the future of intimacy
• Peptides: separating promise from evidence
• Practical Clinical Pearls from Abraham Morgentaler, MD
• Debate: Is testosterone therapy in men overprescribed or under-prescribed?